Virginia Tech Researchers Developed Opioid-Detecting Patch
The wearable device uses microneedles to automatically detect fentanyl and release naloxone during an overdose.
Updated on Oct. 2, 2026 in Substance Abuse

Live Poll
Would you trust a wearable patch to detect and treat a potential drug overdose?
Researchers at Virginia Tech have developed a wearable patch designed to detect fentanyl and automatically release naloxone. The device aims to save the lives of individuals who may suffer an opioid overdose while alone.
Why it matters
Synthetic opioids were involved in 90% of the 107,000 overdose deaths reported in the U.S. in 2022. This new technology provides a potential automated intervention for those at risk of fatal overdose.
The patch utilizes 121 microneedles to access fluid beneath the skin and remains effective for 24 hours after detecting a narcotic. These findings are based on successful testing conducted in mice.
The players
Wujin Sun
He is a researcher at Virginia Tech who has been leading the development of the wearable opioid-detection patch.
Cynthia Haley
She is a participant in the research dialogue surrounding new recovery initiatives based in the Roanoke area.
Virginia Tech
This is a public research university located in Blacksburg that hosts the engineering and medical research teams developing the patch.
The details
The patch functions without a battery or external power, utilizing molecular gates called aptamers that respond to fentanyl by opening to release naloxone. The amount of naloxone released corresponds directly to the level of the narcotic detected.
Timeline
Wujin Sun joined Virginia Tech in 2021.
The U.S. recorded 107,000 overdose deaths in 2022.
Wujin Sun discussed the patch during an interview in August 2026.
Cynthia Haley participated in an interview call on August 31, 2026.
National Recovery Month began on September 1, 2026.
Health Landscape
This innovation follows a broader scientific shift toward automated, wearable medical interventions that remove the need for human action during acute health crises. The technology represents a significant leap from traditional carry-and-use naloxone kits toward proactive, preventative care.
The patch is currently in development with human use estimated to be at least four years away, meaning it is not yet an available treatment option for patients. Future versions may eventually apply this microneedle technology to manage other conditions such as diabetes.
The takeaway
This technology highlights a shift toward automated drug delivery systems that can function without human intervention. While not yet ready for the public, the patch offers a glimpse into how wearable biosensors might eventually manage life-threatening conditions in real-time.
Further reading
For more information on current efforts to address the opioid crisis, visit the Substance Abuse section.
Source note: This article includes information reported by Cardinal News.
Live Poll
Would you trust a wearable patch to detect and treat a potential drug overdose?










